Characterization of the Iatrogenic Drug Risk in Elderly Patients With Chronic Pain Who Consult the Pain Assessment and Treatment Centre at the Nimes University Hospital

Chronic Pain Clinical Trial

— ALGOGER  

Official title:

Characterization of the Iatrogenic Drug Risk in Elderly Patients With Chronic Pain Who Consult the Pain Assessment and Treatment Centre at the Nimes University Hospital

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04006444
• Other study ID #: Local/2017/GL-01
• Status: Completed
• Start date: March 1, 2018
• Est. completion date: June 16, 2018

Study information

• Verified date: June 2019
• Source: Centre Hospitalier Universitaire de Nimes
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Chronic pain may be an additional risk factor for drug iatrogeny due to its management and also drug non-compliance in the geriatric population.

it seems interesting to carry out an inventory of the iatrogenic risk before and after the consultation at the pain centre to enable us to identify the patients most at risk. This study would make it possible to characterize elderly patients with chronic pain, in order to consider, in a future study, setting up a pharmaceutical consultation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: June 16, 2018
• Est. primary completion date: June 16, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years to 100 Years

Eligibility

Inclusion Criteria:

• The patient must be affiliated or beneficiary of a health insurance

• Patient = 65 years old

• Having an outpatient consultation at the pain centre of the Nîmes University hospital of for chronic pain

• Available for pharmaceutical consultation about 30 minutes

Exclusion Criteria:

• It is impossible to give information

• The patient objects to participating in this study

Related Conditions & MeSH terms

• Chronic Pain
• Iatrogenic Drug Risk

Locations

Country	Name	City	State
France	CHU Nimes	Nîmes

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evolution of the ADE Geriatric risk score	The score is calculated on 10 points based on 3 criteria : number of drugs prescribed, prescription of neuroleptics and the initiation of an anticoagulant prescription less than 3 months old. It classifies patients into 3 risk categories: a low risk level for a score of 0 to 1 point, a medium risk level for a score of 2 to 5 points and a high risk level for a score of 6 to 10 points.	2018
Secondary	rate of patients with a low, medium or high risk level calculated by ADE Geriatric risk score according to the type of pain	The score is calculated on 10 points based on 3 criteria : number of drugs prescribed, prescription of neuroleptics and the initiation of an anticoagulant prescription less than 3 months old. It classifies patients into 3 risk categories: a low risk level for a score of 0 to 1 point, a medium risk level for a score of 2 to 5 points and a high risk level for a score of 6 to 10 points.	2018